PulmCCM

Share this post

Biggest losers shed 22 pounds in Qnexa weight loss drug trial

www.pulmccm.org

Discover more from PulmCCM

Life, death and the ICU
Over 39,000 subscribers
Continue reading
Sign in

Biggest losers shed 22 pounds in Qnexa weight loss drug trial

...
Apr 25, 2011
Share this post

Biggest losers shed 22 pounds in Qnexa weight loss drug trial

www.pulmccm.org
Share

Fen-phen died in court, but phenteramine was cleared of all serious charges. Gadde et al report phase III results for Qnexa (by Vivus), a phenteramine-topiramate combination. Over 56 weeks, takers of a double-dose of study drug lost 10 kg; single-dose, 8 kg; and placebo, 1.4 kg. There were plenty of side effects (dry mouth and paresthesias 20%; dysgeusia, insomnia, dizziness, depression & anxiety-related adverse events each in 7% or more at the high dose).(n=2,487). Lancet 2011;377:1341-1352.

Share this post

Biggest losers shed 22 pounds in Qnexa weight loss drug trial

www.pulmccm.org
Share
Previous
Next
Comments
Top
New
Community

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing